Our analyses encompassed differential metabolite profiling, survival analysis, visualization of metabolite disparities between GCA patients and healthy controls, discrimination between early and advanced stage GCA patients, stratification based on HER2 immunohistochemistry staining, and pathway analysis using the KEGG database. Here, ERBB2 is linked to temporal arteritis.